Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platinum Sensitive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07684612
What this trial is testing

Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02)

Who this might be right for
Ovarian Neoplasms
GlaxoSmithKline 690
Early research (Phase 1)Study completedNCT01281514
What this trial is testing

Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

Who this might be right for
Fallopian Tube CancerPeritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Fox Chase Cancer Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494
What this trial is testing

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more
National Cancer Institute (NCI) 29
Large-scale testing (Phase 3)Study completedNCT01968213
What this trial is testing

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
pharmaand GmbH 564
Testing effectiveness (Phase 2)Active Not RecruitingNCT04713514
What this trial is testing

OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

Who this might be right for
Platinum-sensitive Ovarian CancerRelapsed Ovarian Cancer
ARCAGY/ GINECO GROUP 180
Large-scale testing (Phase 3)Study completedNCT01204749
What this trial is testing

TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
Amgen 919
Testing effectiveness (Phase 2)Ended earlyNCT00006812
What this trial is testing

Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01481701
What this trial is testing

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Who this might be right for
Ovarian CarcinomaRelapse
Jules Bordet Institute 90
Testing effectiveness (Phase 2)Study completedNCT02004093
What this trial is testing

Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 149
Not applicableLooking for participantsNCT06292286
What this trial is testing

Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer

Who this might be right for
Recurrent Ovarian Carcinoma
The University of Hong Kong 18
Testing effectiveness (Phase 2)Study completedNCT02983799
What this trial is testing

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Who this might be right for
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
AstraZeneca 272
Testing effectiveness (Phase 2)Study completedNCT01033123
What this trial is testing

A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sanofi 41
Early research (Phase 1)Study completedNCT00473954
What this trial is testing

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
EGEN, Inc. 13
Not applicableUnknownNCT01851746
What this trial is testing

Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Wuhan University 200
Testing effectiveness (Phase 2)WithdrawnNCT01624493
What this trial is testing

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Hoosier Cancer Research Network
Not applicableUnknownNCT04920721
What this trial is testing

Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy

Who this might be right for
Drug Allergy
Central Hospital, Nancy, France 62
Large-scale testing (Phase 3)WithdrawnNCT03632798
What this trial is testing

Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Cordgenics, LLC
Testing effectiveness (Phase 2)Ended earlyNCT01035658
What this trial is testing

Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
SCRI Development Innovations, LLC 22
Testing effectiveness (Phase 2)UnknownNCT04661696
What this trial is testing

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

Who this might be right for
Ovarian Cancer
Chinese Academy of Medical Sciences 75
Testing effectiveness (Phase 2)Study completedNCT00116610
What this trial is testing

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Poniard Pharmaceuticals 75
Next Page